Position in JANX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,950,000
-$10,158,000 QoQ
Shares Held
500,000
-28.6% QoQ
Ownership
0.820%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in JANX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TANG CAPITAL MANAGEMENT LLC holds $1,633,796,726 across 44 Biotechnology names. JANX ranks #26 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AUPH |
Aurinia Pharmaceuticals Inc.
|
12,229,500 | $181,241,190 | |
| 2 | CELC |
Celcuity Inc.
|
1,050,000 | $119,847,000 | |
| 3 | MIRM |
Mirum Pharmaceuticals, Inc.
|
1,236,027 | $114,184,174 | |
| 4 | LKFT |
Lakefront Biotherapeutics NV
|
3,785,991 | $113,579,730 | |
| 5 | CAPR |
Capricor Therapeutics, Inc.
|
3,399,900 | $103,356,960 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
1,500,000 | $102,195,000 | |
| 7 | SYRE |
Spyre Therapeutics, Inc.
|
1,892,200 | $95,442,568 | |
| 8 | KALV |
KalVista Pharmaceuticals, Inc.
|
4,573,530 | $92,065,158 |
All Filings in JANX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,950,000 | 500,000 | Shares | Other | 2026-05-15 | |
| 2025-09-30 | $17,108,000 | 700,000 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $4,620,000 | 200,000 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $4,050,000 | 150,000 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $2,677,000 | 50,000 | Shares | Other | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||